Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
10 February 2006. Related: Conference reports, Paediatric care.
Conference reports
African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
10 February 2006. Related: Conference reports, Side effects.
Predictors of insulin resistance in first year of therapy
10 February 2006. Related: Conference reports, Side effects.
Three measures confirm 144-week renal record of tenofovir
10 February 2006. Related: Conference reports, Antiretrovirals.
Low rash risk with efavirenz after nevirapine rash
10 February 2006. Related: Conference reports, Antiretrovirals.
7th Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13-16 November 2005, Dublin, Ireland
13 December 2005. Related: Conference reports.
Monitoring side effects in resource limited countries
13 December 2005. Related: Conference reports, Side effects.
Uridine supplement reverses thymidine-induced lipoatrophy
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Pravastatin increases limb fat in HIV-positive patients with hypercholesterolaemia
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Evidence that facial fat can return after switching from either d4T or AZT, to abacavir or tenofovir
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Niacin has beneficial effect on lipids but no reduction in abdominal fat
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Gluteal implants used to replace lost buttock fat
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
10th European AIDS Conference, 17-20 November 2005, Dublin, Ireland
13 December 2005. Related: Conference reports.
Pregnancy studies at EACS
13 December 2005. Related: Conference reports, Pregnancy.
Further Reports from 3rd IAS Conference on AIDS Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005
13 October 2005. Related: Conference reports.
Management of hepatitis C and B in HIV-coinfected individuals: an overview of studies presented at the 3rd IAS Conference
13 October 2005. Related: Conference reports, Hepatitis coinfection.
Highlights of HIV drug resistance studies presented at the 3rd IAS Conference
13 October 2005. Related: Conference reports, Drug resistance.
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
14 September 2005. Related: Conference reports.
Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy
14 September 2005. Related: Conference reports, HIV prevention and transmission.
Benefits of adding 4 or 7 days of AZT/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS
14 September 2005. Related: Conference reports, Pregnancy.
New drugs in pregnancy: atazanavir; T20
14 September 2005. Related: Conference reports, Pregnancy.
Lopinavir/r use in children less than two years old promising results despite low plasma levels
14 September 2005. Related: Conference reports, Paediatric care.
Favourable outcomes in children treated with HAART in the MSF programmes
14 September 2005. Related: Conference reports, Paediatric care.
Encouraging results with cut up generic fixed dose combination tablets in Uganda
14 September 2005. Related: Conference reports, Paediatric care.
Predictors of survival at three years follow up for HIV-infected children in Cote D’Ivoire
14 September 2005. Related: Conference reports, Paediatric care.
Benefit of maintaining the M184V mutation with 3TC monotherapy: final 48-week results
14 September 2005. Related: Conference reports, Antiretrovirals.
T20 (enfuvirtide) studies presented at Rio
14 September 2005. Related: Conference reports.
Strategies for salvage therapy
14 September 2005. Related: Conference reports, Antiretrovirals.
Antiviral activity of foscarnet in salvage patients
14 September 2005. Related: Conference reports, Antiretrovirals.
Novel strategies with existing drugs
14 September 2005. Related: Conference reports, Antiretrovirals.
Antiretroviral activity of new and novel agents
14 September 2005. Related: Conference reports, Antiretrovirals.
Overview of pharmacology studies
14 September 2005. Related: Conference reports, PK and drug interactions.
Incidence of TB infection despite HAART and treatment in coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV/TB coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Does WHO clinical stage reliably predict who should receive ARV treatment?
14 September 2005. Related: Conference reports, Treatment access.
Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
14 September 2005. Related: Conference reports, Treatment access.
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
14 August 2005. Related: Conference reports.
Keystone vaccine symposia 2005: vaccines, pathogenesis, snow and a couple of elk
14 August 2005. Related: Conference reports, Vaccines and microbicides.
14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada
15 July 2005. Related: Conference reports.
Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors
15 July 2005. Related: Conference reports, Basic science and immunology.
Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant
15 July 2005. Related: Conference reports, Pregnancy.
Reduced replicative capacity of M184V explains benefit of 3TC monotherapy compared to stopping all drugs
14 July 2005. Related: Conference reports, Antiretrovirals.
Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure
14 July 2005. Related: Conference reports, Drug resistance.
Predicting clinical responses to ddI from genotypic resistance
14 July 2005. Related: Conference reports, Drug resistance.
Under-detection of transmission of transmitted resistance and impact on treatment response
14 July 2005. Related: Conference reports, Drug resistance.
Risk of death in UK after diagnosis of 3-class resistance
14 July 2005. Related: Conference reports, Drug resistance.
11th BHIVA and BASSH joint annual conference, 22-25 April 2005, Dublin
15 June 2005. Related: Conference reports.
Long-awaited UK pregnancy guidelines now updated; pregnancy studies in Dublin
15 June 2005. Related: Conference reports, Pregnancy.
Underdosing of ARVs in children: results from CHIPS cohort
15 June 2005. Related: Conference reports, Paediatric care.
Sexual transmission and response to treatment in acute HCV infection in HIV-positive gay men coinfected with HIV
15 June 2005. Related: Conference reports, Hepatitis coinfection.
Levels of efavirenz 10-fold above minimum target level despite coadministration with rifampicin
15 June 2005. Related: Conference reports, PK and drug interactions, Side effects.
Schistosomiasis after immune reconstitution: symptoms appear as HAART side effects
15 June 2005. Related: Conference reports, Coinfections and complications.
6th International Workshop on Clinical Pharmacology of HIV Therapy, 28-30 April 2005, Quebec, Canada
15 June 2005. Related: Conference reports.
Effect of age/menopause on lopinavir and efavirenz concentrations in women
15 June 2005. Related: Conference reports, Women's health.
Effect of age on lopinavir concentrations
15 June 2005. Related: Conference reports, Antiretrovirals.
Gender and pharmacokinetics of saquinavir
15 June 2005. Related: Conference reports, Antiretrovirals.
Dosing nevirapine in children
15 June 2005. Related: Conference reports, Paediatric care.
Intracellular NRTI-triphosphate levels in children are similar to adults
15 June 2005. Related: Conference reports, Paediatric care.
Efavirenz and rifampicin: lower body weight associated with higher concentrations
15 June 2005. Related: Conference reports, TB coinfection.
Summary of drug-drug interaction studies
15 June 2005. Related: Conference reports, PK and drug interactions.
Responses to atazanavir, Kaletra and side effects
15 June 2005. Related: Conference reports, Antiretrovirals.
3rd European HIV Drug Resistance Workshop, 30 March-1 April 2005, Athens
15 May 2005. Related: Conference reports.
Tenofovir, nucleosides, and non-nucleosides
15 May 2005. Related: Conference reports, Drug resistance.
Protease inhibitors
15 May 2005. Related: Conference reports, Drug resistance.
CCR5 antagonists
15 May 2005. Related: Conference reports, Drug resistance.